(066) A Low Androgen State Impairs Erectile Function by Suppressing EPAC1 in Rat Corpus Cavernosum Penis

J Rui,L Xi,L Hao,K Xiangjun,X Wen-Ju,J Rui

DOI: https://doi.org/10.1093/jsxmed/qdae002.061

2024-03-06

The Journal of Sexual Medicine

Abstract:Introduction The relationship among exchange proteins activated by cAMP 1(EPAC1), androgen and erectile function is still unknown. Objective To explore whether EPAC1 expresses in penile corpus cavernosum of rats and how EPAC1 affects erectile function under low androgenic conditions. Methods Thirty 8-week-old healthy male rats were randomly divided into six groups (n=5): sham operation (sham), castrated, castrated + testosterone replacement (castrated + T), sham + EPAC1 over-expression lentivirus (sham + EPAC1), castrated + empty lentivirus vector (castrated + empty vector), and castrated + EPAC1. Four weeks after the operation, the lentivirus vectors carrying the EPAC1 gene were injected into the corpus cavernosum penis tissues of the sham + EPAC1 and castrated + EPAC1 groups (1×108TU/ml, 20 μl per rat). A week after injection, the ratio of maximum intracavernous pressure to mean arterial pressure (ICPmax/MAP) and the levels of serum testosterone (T), nitric oxide (NO), the active form of ras homolog gene family, member A (RhoA-GTP), protein kinase B (AKT), phospho-AKT (p-AKT), endothelial nitric oxide synthase (eNOS), phospho-eNOS (p-eNOS), p-AKT/AKT, p-eNOS/eNOS and EPAC1 levels were measured. Results EPAC1 is primarily located in the cytoplasm of endothelial cells and smooth muscle cells in the rat corpus cavernosum penis. In comparison to the sham group, the T, ICPmax/MAP and NO levels of the castrated group were notably reduced (p < 0.01). Meanwhile, the RhoA-GTP concentration in the castrated + EPAC1 group was reduced in comparison with the castrated + empty vector group (p < 0.01). Compared with the castrated + empty vector group, the p-AKT/AKT, EPAC1 and p-eNOS/eNOS levels in the castrated + EPAC1 group were significantly increased (p < 0.05). Conclusions Androgen deficiency can suppress EPAC1 expression in the penile corpus cavernosum of rats, while the up-regulation of which can improve the erectile function of castrated rats. Disclosure Yes, this is sponsored by industry/sponsor: This study was supported by the Research Foundation of the Department of Human Resources and Social Security of Sichuan Province of Returned Scholars grant 2019-76. Clarification: No industry support in study design or execution.

urology & nephrology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore how androgen deficiency affects the expression of Exchange Protein Activated by cAMP 1 (EPAC1) in the corpus cavernosum of the penis, and further study the impact of EPAC1 on erectile function under low - androgen conditions.

Specifically, the researchers hope to verify the following hypotheses through experiments:
1. **Whether EPAC1 is expressed in the corpus cavernosum of rats**: First, confirm the presence of EPAC1 in the target tissue.
2. **How EPAC1 affects erectile function under low - androgen conditions**: By regulating the expression level of EPAC1, observe its impact on indicators related to erectile function.

### Main research methods
- **Animal model**: Use 30 healthy 8 - week - old male rats and randomly divide them into 6 groups (5 rats in each group):
- Sham - operated group (Sham)
- Castrated group (Castrated)
- Castrated + testosterone replacement group (Castrated + T)
- Sham - operated + EPAC1 over - expression lentivirus group (Sham + EPAC1)
- Castrated + empty vector lentivirus group (Castrated + Empty Vector)
- Castrated + EPAC1 over - expression lentivirus group (Castrated + EPAC1)

- **Experimental steps**:
- Perform castration surgery on the castrated group, and perform corresponding treatments on other groups.
- Four weeks later, inject the lentiviral vector carrying the EPAC1 gene (1 × 10^8 TU/ml, 20 µl per rat) into the corpus cavernosum of the penis in the Sham + EPAC1 group and the Castrated + EPAC1 group.
- One week after injection, measure the ratio of maximum intracavernous pressure to mean arterial pressure (ICPmax/MAP), serum testosterone (T), nitric oxide (NO), active Ras homologous gene family member A (RhoA - GTP), protein kinase B (AKT), phosphorylated AKT (p - AKT), endothelial nitric oxide synthase (eNOS), phosphorylated eNOS (p - eNOS), p - AKT/AKT ratio, p - eNOS/eNOS ratio and EPAC1 level in each group.

### Main results
- **Location of EPAC1**: EPAC1 is mainly located in the cytoplasm of endothelial cells and smooth muscle cells in the corpus cavernosum of rats.
- **Changes in the castrated group**: Compared with the sham - operated group, the levels of testosterone (T), ICPmax/MAP and NO in the castrated group were significantly decreased (p < 0.01).
- **Impact of EPAC1 over - expression**: Compared with the Castrated + empty vector group, the RhoA - GTP concentration in the Castrated + EPAC1 group was significantly decreased (p < 0.01), while the p - AKT/AKT, EPAC1 and p - eNOS/eNOS levels were significantly increased (p < 0.05).

### Conclusion
- Androgen deficiency can inhibit the expression of EPAC1 in the corpus cavernosum of rats, and the up - regulation of EPAC1 can improve the erectile function of castrated rats.

Through these studies, the authors hope to reveal the relationship between androgen, EPAC1 and erectile function, and provide new ideas and targets for the treatment of erectile dysfunction.